Bioavailability of quercetin in various forms of administration and its implications for the antihypertensive effect [Biodisponibilidad de quercetina bajo distintas formas de administracion y sus implicaciones sobre el efecto antihipertensivo]

Trial Profile

Bioavailability of quercetin in various forms of administration and its implications for the antihypertensive effect [Biodisponibilidad de quercetina bajo distintas formas de administracion y sus implicaciones sobre el efecto antihipertensivo]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Aug 2011

At a glance

  • Drugs Quercetin (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top